Oxford Biomedical Technologies

10/29/2025

Oxford Biomedical Technologies presented research at the American Society for Nutrition (ASN) Conference 2025!

Objectives: To examine the effectiveness of the Lifestyle Eating and Performance (LEAP) program in alleviating gastrointestinal symptoms in individuals with irritable bowel syndrome (IBS).

10/28/2025

We are excited to announce OBT's latest publication, featured at FNCE 2025.

Provide scientific evidence to support improvements in nutrition and health for individuals with medical conditions.

10/23/2025

Oxford Biomedical Technologies had an amazing time at FNCE 2025! It was a wonderful experience connecting with everyone at the conference.

07/08/2024

https://cdn.nutrition.org/article/S2475-2991(24)00325-1/fulltext
Latest published research presented at the American Society for Nutrition 2024 Conference in Chicago!

Objectives: To investigate the effectiveness of a 12-week patient-specific oligoantigenic diet on global symptomatology for irritable bowel syndrome (IBS).

04/26/2024

Congratulations! Your abstract "A Novel Tailored Oligoantigenic Dietary Approach for Irritable Bowel Syndrome (IBS)" was peer reviewed for the 2024 Food & Nutrition Conference & Expo™ (FNCE®) and selected for a poster session.

03/25/2024

Congratulations! On behalf of the American Society for Nutrition, we are delighted to notify you that your abstract has been accepted for presentation at NUTRITION 2024.
Abstract Title: Effectiveness of a Patient-Specific Oligoantigenic Diet on Global Symptoms for Irritable Bowel Syndrome.

10/11/2023

Latest Publication Presented at FNCE 2023 from the Research Department at Oxford Biomedical Technologies, Inc.

Provide scientific evidence to support the improvement of nutrition and overall health care for individuals with medical conditions.

10/03/2023

Hello Everybody,
FNCE is quickly approaching! Below is the information for the poster session that Oxford Biomedical Technologies is presenting.

Clinical Response to Personalized Dietary Therapy for Irritable Bowel Syndrome (IBS)
Sunday October 8, 2023
11:45 AM – 1:15 PM
Your Role: Poster Presenter
Poster Number: 57

07/19/2023

FREE Full Text Access - Oxford Biomedical Technologies Publication.
Please review the findings from our research on the clinical effectiveness of the Lifestyle Eating and Performance (LEAP) program based on the Leukocyte Activation Assay-MRT (LAA-MRT) results in improving IBS symptoms and quality of life.

Introduction: Adverse reactions to foods and food additives have a critical role in clinical manifestations of irritable bowel syndrome (IBS). Personalized dietary modifications conducted under the supervision of a qualified health practitioner could considerably impact the clinical car...

04/24/2023

Your abstract was peer reviewed for the 2023 Food & Nutrition Conference & Expo™ (FNCE®) and selected for a poster session. FNCE® will be held October 7-10, 2023 in Denver, CO at the Colorado Convention Center.

04/04/2023

Congratulations! On behalf of the American Society for Nutrition, we are delighted to notify you that your abstract has been accepted for presentation at NUTRITION 2023.
Abstract Title: Evaluation of the Lifestyle Eating and Performance (LEAP) Program To Manage Symptoms and Quality of Life for Irritable Bowel Syndrome (IBS).

08/19/2022

We were very pleased with the scope and quality of the submissions, and are happy to inform you that the abstract entitled “Effectiveness of the Lifestyle Eating and Performance (LEAP) program for Irritable Bowel Syndrome (IBS)” was accepted for the Lifestyle Medicine 2022 conference!